Title: A Study on Role of USG Guided FNAC in Chronic Pancreatitis with Headmass

Authors: Dr Pon Chidambaram Mch, Dr U. Aravindan Mch, Dr Mohammed Niyamathullah

 DOI: https://dx.doi.org/10.18535/jmscr/v6i10.220

Abstract

Pancreatic cancer is one of the leading causes of death among gastrointestinal malignancies. Chronic pancreatitis (CP) is strongly associated with pancreatic malignancy and may be the causative factor. Most of the pancreatic tumours (70 %) and most of inflammatory masses in CP are situated in the head of pancreas. Common pancreatic malignancies include adenocarcinomas (90%), cystic neoplasms (5%), and neuroendocrine tumors (2-5%). Preoperative tissue diagnosis is necessary in certain situations. The common techniques used to image pancreas are computerised tomography (CT), abdominal ultrasound, endoscopic ultrasonography (EUS) and ERCP. For those patients who have an imaging characteristic of benign disease, either conservative or drainage procedures can be performed. For patients who have an imaging characteristic of malignant head mass, pancreatico-duodenectomy or palliative procedure can be performed depending on the stage of the disease. There exists an indeterminate group of patients who cannot be categorised as benign or malignant based on imaging. It is for this group of patients where tissue diagnosis plays an important role for proper treatment selection for the patient. Ultrasound (USG) guided fine needle aspiration cytology (FNAC) is a highly useful tool in this subset of patients with indeterminate mass. In this study we have evaluated various etiological factors. diagnostic modalities and effective usefulness of ultrasound guided FNAC in diagnosis of malignancy in chronic pancreatitis with head mass and its management.

Keywords: Tumor markers, USG guided FNAC, pancreatectomy.

References

  1. Zografos GN, Bean AG, Bowles M, Williamson RC (1997). Chronic pancreatitis and neoplasia: correlation or coincidence. HPB Surg 10:235–239.
  2. Perumal S, Palaniappan R, Pillai SA, Velayutham V, Sathyanesan J (2013) Predictors of malignancy in chronic calcific pancreatitis with head mass. World J GastrointestSurg 5(4):97–103.
  3. Mohan V, Premalatha G, Pitchumoni CS (2003) Tropical chronic pancreatitis: an update. J ClinGastroenterol 36:337–346.
  4. Falconi M, Casetti L, Salvia R, Sartori N, Bettini R, Mascetta G et al (2000) Pancreatic head mass, how can we treat it? Chronic pancreatitis: surgical treatment. JOP 1:154–161.
  5. DL Clarke, NG Lazarus, et al. The role of preoperative biopsy in pancreatic cancer. HPB 2004;6:144-53.
  6. kouraklis G, Glinavou A, Karayiannakis A, Karatzas G, Primary tuberculosis of the pancreas mimicking a pancreatic tumorInt J Pancreatol 2001;29:151-3
  7. Minghini A, Weireter LJ, Perry RR (1998) Specificity of elevated CA 19-9 levels in chronic pancreatitis. Surgery 124:103–105.
  8. Shahangian S, Herbert A, Fritsche JR et al., Pancreatic oncofetal antigen and carbohydrate antigen 19-9 in sera of patients with cancer of pancreas. Clin Chem; 35(3):405-8.
  9. Gudjohnsson, RE, Bolden S, Wingo PA.,1987. Cancer 1987. CA Cancer J Clin; 48 (1):6-29.
  10. Ahmed NA, Lewis JD, Ginsberg GG et al., EUS in preoperative staging of pancreatic cancer. Gastrointest Endosc Oct; 52(4): 463-8.

Corresponding Author

Dr Mohammed Niyamathullah

Assistant Surgeon, Govt Hospital Kumbakonam